Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without Inhibitor
Clinical trial NCT05619926 · COMPLETED
Trial details
- NCT number
- NCT05619926
- Sponsor
- Staidson (Beijing) Biopharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-09
- Primary completion
- 2023-08-25
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.